Dendreon Announces Webcast Presentations at Upcoming Conferences

  Dendreon Announces Webcast Presentations at Upcoming Conferences

dbAccess BioFEST 2012 31st Annual J.P. Morgan Healthcare Conference

Business Wire

SEATTLE -- November 27, 2012

November 27, 2012--Dendreon Corporation (Nasdaq:DNDN) today announced that
management will present at the following conferences:

  *2012 dbAccess BioFEST in Boston, MA, on December 4, 2012, at 2:15 p.m. ET
  *31^st Annual J.P. Morgan Healthcare Conference in San Francisco, CA, on
    January 7, 2013, at 3:30 p.m. PT

The presentations will be webcast live and available for replay from
Dendreon's website, www.dendreon.com. If you are unable to listen to the live
webcast, it will be archived on the site following the presentation. To access
the replay, go to the Investor Relations section of the website.

About Dendreon

Dendreon Corporation is a biotechnology company whose mission is to target
cancer and transform lives through the discovery, development,
commercialization and manufacturing of novel therapeutics. The Company applies
its expertise in antigen identification, engineering and cell processing to
produce active cellular immunotherapy (ACI) product candidates designed to
stimulate an immune response in a variety of tumor types. Dendreon's first
product, PROVENGE® (sipuleucel-T), was approved by the U.S. Food and Drug
Administration (FDA) in April 2010. Dendreon is exploring the application of
additional ACI product candidates and small molecules for the potential
treatment of a variety of cancers. The Company is headquartered in Seattle,
Washington and is traded on the NASDAQ Global Market under the symbol DNDN.
For more information about the Company and its programs, visit
http://www.dendreon.com/.

Contact:

Dendreon Corporation
Nicole Soley, 206-455-2220
Investor Relations
InvestorRelations@dendreon.com
 
Press spacebar to pause and continue. Press esc to stop.